Centre for Global Health Policy

Suggested reading list

Our panel conveners have identified the following readings as useful background material to their panel.

Panel 1. Closing the Gap in Health Inequalities – is Genomics Part of the Solution?

D. Gurwitz ,  Zika E.,Hopkins M.M. ,Gaisser S. , Ibarreta D. Pharmacogenetics in Europe: Barriers and Opportunities Public Health Genomics 2009;12:134–141.

M. M. Hopkins, Martin, Paul A, Nightingale, Paul, Kraft, Alison and Mahdi, Surya (2007) The myth of the biotech revolution: an assessment of technological, clinical and organisational change. Research Policy, 36 (4). pp. 566-589. 

T. Pang and D.J. Weatherall (2012) Genomics and World Health: a decade on. May 19, 2012; 379: 1853-1854.


Panel 2: Personal Genome Project (PGP)-UK and Genetic Privacy

Dickenson, Donna (2013) Me Medicine vs. We Medicine: Reclaiming Biotechnology for the Common Good. New York: Columbia University Press.

Tutton, Richard & Oonagh Corrigan (2004) Genetic Databases: Socio-ethical issues in the collection and use of DNA. New York: Routledge.

Wallace, Helen (2014) GeneWatch UK response to the Nuffield Council on Bioethics’ consultation on the linking and use of biological and health data. Available at: http://www.genewatch.org/uploads/f03c6d66a9b354535738483c1c3d49e4/Nuffieldbiodata_GWresponse_fin2.pdf


Panel 3. Manipulated Microbes: Genetics, Genomics and Global Health Security

Elbe, Stefan and Anne Roemer-Mahler. 2014. Pharmaceuticals and Security: Strengthening Industry Engagement. Summary Report. https://www.sussex.ac.uk/webteam/gateway/file.php?name=erc-report.pdf&site=346  

Herfst, Sander, Eefje Schrauwen, Artin Linster, Chutinimitkul et al. 2013. Airborne transmission of Influenza A/H5N1 virus between ferrets. Science, 336;1534-1541.

Imai, Masaki, Tokiko Watanabe, Masato Hatta, Subash Das et al. 2013. Experimental adaptation of an influenza H5HA reassortant H5 HA/H1N1 virus in ferrets. Nature, 486:420-428.

Lipsitch M and Galvani AP. 2014. Ethical Alternatives to Experiments with Novel Potential Pandemic Pathogens. PLoS Med 11(5): e1001646. DOI:10.1371/journal.pmed.1001646.


Panel 4. Emerging Molecular Diagnostics – What are the Challenges to Widespread Implementation?

M. M. Hopkins, Ibarreta, Dolores, Gaisser, Sibylle, Enzing, Christien M, Nightingale, Paul et al, (2006) Putting pharmacogenetics into practice.Nature Biotechnology, 24 (4). pp. 403-410.

R. W. Peeling and D. Mabey. Point-of-care tests for diagnosing infections in the developing world. Clin. Microbiol. Infec.  16: 1062–106

Cathy A. Petti, Christopher R. Polage, Thomas C. Quinn,  Allan R. Ronald, and Merle A. Sande. Laboratory Medicine in Africa: A Barrier to Effective. CID 2006:42 (1 February)


Panel 5. Genetic Discrimination and Genetic Identities in Non-Western Societies

Berthier-Foglar, Sheila Collingwood-Whittick and Sandrine Tolazzi (2012) Biomapping Indigenous Peoples. Towards and understanding of the issues. Amsterdam & New York: Rodolpi

Gibbon, Sarah and Novas, Carlos (eds). 2008. Biosocialities, Identity and the Social Sciences London, Routledge

Sleeboom-Faulkner, M. (ed.) (2010) Frameworks of Choice: Predictive & Genetic Testing in Asia, Amsterdam: University of Amsterdam Press.


Panel 6. Bioinformation Economies: Benefits and Insecurities for Genomic Global Health

Bronwyn Parry. 2004.  Trading the Genome: Investigating the Commodification of Bio-Information.  Columbia University Press.

Harvey, M., McMeekin, A. (2009). Public or private economies of knowledge: The economics of diffusion and appropriation of bioinformatics tools. International Journal of the Commons, North America, vol 4,  At: <http://www.thecommonsjournal.org/index.php/ijc/article/view/144/148

Hinterberger, Amy. 2012. Investing in Life, Investing in Difference: Nations, Populations and Genomes. Theory, Culture and Society, 29(3): 72–93.

Leonelli S. 2014. What Difference Does Quantity Make? On the Epistemology of Big Data Biology, Big Data & Society 1, 1: doi: 10.1177/2053951714534395 April-June 2014

Lewis J.  and Bartlett A. (2013)  Inscribing a discipline: tensions in the field of Bioinformatics. New Genetics and Society, Vol. 32, No. 3, 243–263.